Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The role of low molecular weight thiols in Mycobacterium tuberculosis.

Sao Emani C, Gallant JL, Wiid IJ, Baker B.

Tuberculosis (Edinb). 2019 May;116:44-55. doi: 10.1016/j.tube.2019.04.003. Epub 2019 Apr 23. Review.

PMID:
31153518
2.

Generation and characterization of thiol-deficient Mycobacterium tuberculosis mutants.

Sao Emani C, Williams MJ, Van Helden PD, Taylor MJC, Carolis C, Wiid IJ, Baker B.

Sci Data. 2018 Sep 25;5:180184. doi: 10.1038/sdata.2018.184.

3.

The functional interplay of low molecular weight thiols in Mycobacterium tuberculosis.

Sao Emani C, Williams MJ, Wiid IJ, Baker B.

J Biomed Sci. 2018 Jul 12;25(1):55. doi: 10.1186/s12929-018-0458-9.

4.

Compounds with Potential Activity against Mycobacterium tuberculosis.

Sao Emani C, Williams MJ, Wiid IJ, Baker B, Carolis C.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02236-17. doi: 10.1128/AAC.02236-17. Print 2018 Apr.

5.

Gamma-glutamylcysteine protects ergothioneine-deficient Mycobacterium tuberculosis mutants against oxidative and nitrosative stress.

Sao Emani C, Williams MJ, Van Helden PD, Taylor MJC, Wiid IJ, Baker B.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):174-178. doi: 10.1016/j.bbrc.2017.10.163. Epub 2017 Oct 31.

PMID:
29101028
6.

Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress.

Gallant JL, Viljoen AJ, van Helden PD, Wiid IJ.

PLoS One. 2016 Jan 29;11(1):e0147706. doi: 10.1371/journal.pone.0147706. eCollection 2016.

7.

Effect of milk fermentation by kefir grains and selected single strains of lactic acid bacteria on the survival of Mycobacterium bovis BCG.

Macuamule CL, Wiid IJ, van Helden PD, Tanner M, Witthuhn RC.

Int J Food Microbiol. 2016 Jan 18;217:170-6. doi: 10.1016/j.ijfoodmicro.2015.10.024. Epub 2015 Oct 25.

PMID:
26544204
8.

A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.

Locher CP, Jones SM, Hanzelka BL, Perola E, Shoen CM, Cynamon MH, Ngwane AH, Wiid IJ, van Helden PD, Betoudji F, Nuermberger EL, Thomson JA.

Antimicrob Agents Chemother. 2015 Mar;59(3):1455-65. doi: 10.1128/AAC.04347-14. Epub 2014 Dec 22.

9.

In vitro study of beneficial properties and safety of lactic acid bacteria isolated from Portuguese fermented meat products.

Todorov SD, Franco BD, Wiid IJ.

Benef Microbes. 2014 Sep;5(3):351-66. doi: 10.3920/BM2013.0030.

PMID:
24463204
10.

The role of glutamine oxoglutarate aminotransferase and glutamate dehydrogenase in nitrogen metabolism in Mycobacterium bovis BCG.

Viljoen AJ, Kirsten CJ, Baker B, van Helden PD, Wiid IJ.

PLoS One. 2013 Dec 19;8(12):e84452. doi: 10.1371/journal.pone.0084452. eCollection 2013.

11.

Ergothioneine is a secreted antioxidant in Mycobacterium smegmatis.

Sao Emani C, Williams MJ, Wiid IJ, Hiten NF, Viljoen AJ, Pietersen RD, van Helden PD, Baker B.

Antimicrob Agents Chemother. 2013 Jul;57(7):3202-7. doi: 10.1128/AAC.02572-12. Epub 2013 Apr 29.

12.

Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.

Hans RH, Wiid IJ, van Helden PD, Wan B, Franzblau SG, Gut J, Rosenthal PJ, Chibale K.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):2055-8. doi: 10.1016/j.bmcl.2011.02.008. Epub 2011 Mar 2.

PMID:
21376591
13.

Glutamine synthetase sequence evolution in the mycobacteria and their use as molecular markers for Actinobacteria speciation.

Hayward D, van Helden PD, Wiid IJ.

BMC Evol Biol. 2009 Feb 26;9:48. doi: 10.1186/1471-2148-9-48.

14.

Measuring minimum inhibitory concentrations in mycobacteria.

Sirgel FA, Wiid IJ, van Helden PD.

Methods Mol Biol. 2009;465:173-86. doi: 10.1007/978-1-59745-207-6_11.

PMID:
20560078
15.

Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model.

Loots DT, Wiid IJ, Page BJ, Mienie LJ, van Helden PD.

J Pineal Res. 2005 Mar;38(2):100-6.

PMID:
15683464
16.

Oligonucleotide (GTG)5 as an epidemiological tool in the study of nontuberculous mycobacteria.

Cilliers FJ, Warren RM, Hauman JH, Wiid IJ, van Helden PD.

J Clin Microbiol. 1997 Jun;35(6):1545-9.

17.

Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line.

van Helden PD, Wiid IJ, Hoal-van Helden EG, Bey E, Cohen R.

Br J Cancer. 1994 Aug;70(2):195-8.

18.

Oligonucleotide (GTG)5 as a marker for Mycobacterium tuberculosis strain identification.

Wiid IJ, Werely C, Beyers N, Donald P, van Helden PD.

J Clin Microbiol. 1994 May;32(5):1318-21.

19.

An inexpensive approach to ultracentrifugation of small volume suspensions.

Wiid IJ, Huisamen B.

Biotechniques. 1993 Apr;14(4):564. No abstract available.

PMID:
8476598
20.

Chronic atrophic gastritis, gastric pH, nitrites and micronutrient levels in a population at risk for gastric carcinoma.

Jaskiewicz K, Van Helden PD, Wiid IJ, Steenkamp HJ, Van Wyk MJ.

Anticancer Res. 1990 May-Jun;10(3):833-6.

PMID:
2369096
21.

Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis.

van Helden PD, Wiid IJ, Albrecht CF, Theron E, Thornley AL, Hoal-van Helden EG.

Cancer Res. 1988 Oct 15;48(20):5660-2.

22.

Structural alterations in chromatin during myogenesis in the chicken.

Wiid IJ, Durrheim G, Bester AJ, van Helden PD.

Mol Cell Biochem. 1988 Jan;79(1):57-62.

PMID:
2453787
23.

Evidence for transcriptional regulation of the myosin heavy chain gene during myogenesis.

Wiid IJ, Boyd CD, Bester AJ, Van Helden PD.

Nucleic Acids Res. 1984 Mar 26;12(6):2717-29.

Supplemental Content

Support Center